A Kurtaran Selected Research

Radioisotopes (Radionuclides)

7/2011	Improved quality of life in patients treated with Peptide radionuclides.
5/2003	Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
1/2002	Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
6/2001	New trends in peptide receptor radioligands.
1/2001	Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Kurtaran Research Topics

Disease

9	Neoplasms (Cancer) 07/2011 - 03/2000
4	Carcinoid Tumor (Carcinoid) 06/2003 - 03/2000
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2002 - 01/2001
3	Neoplasm Metastasis (Metastasis) 08/2003 - 12/2000
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2002 - 06/2001
2	Papillary Thyroid Cancer 05/2003 - 02/2003
2	Lung Neoplasms (Lung Cancer) 01/2002 - 09/2001
2	Liver Neoplasms (Liver Cancer) 01/2002 - 06/2000
2	Lymphoma (Lymphomas) 11/2001 - 09/2001
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2013
1	Wounds and Injuries (Trauma) 09/2013
1	Paraplegia (Spastic Paraplegia) 09/2013
1	Quadriplegia (Spastic Quadriplegia) 09/2013
1	Spinal Injuries (Spinal Injury) 09/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2013
1	Heel Spur (Heel Spurs) 02/2012
1	Hepatitis B 12/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2010
1	Mycosis Fungoides 01/2010
1	Secondary Hyperparathyroidism 10/2003
1	Neurilemmoma (Schwannoma) 08/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2003
1	Nausea 02/2002
1	Carcinoma (Carcinomatosis) 02/2002
1	Weight Gain 02/2002
1	Adenocarcinoma 02/2002
1	Thyroid Neoplasms (Thyroid Cancer) 01/2002
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 11/2001
1	Familial primary gastric lymphoma 11/2001
1	Endemic Goiter 07/2001
1	Thyroid Diseases (Thyroid Disease) 07/2001
1	Primary Hyperparathyroidism 07/2001
1	Disease Progression 06/2000
1	Myocardial Infarction 01/2000

Drug/Important Bio-Agent (IBA)

8	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2011 - 06/2001
7	lanreotide (Somatuline)FDA Link 02/2002 - 03/2000
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2002 - 03/2000
5	Radioisotopes (Radionuclides)IBA 07/2011 - 01/2001
4	Octreotide (Sandostatin)FDA LinkGeneric 01/2002 - 03/2000
3	Peptide Receptors (Peptide Receptor)IBA 07/2011 - 03/2000
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2002 - 03/2000
3	indium 111-DOTA-lanreotideIBA 09/2001 - 01/2001
2	Iodine-131IBA 05/2003 - 02/2003
2	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 07/2001 - 01/2000
1	Fatty Acid-Binding ProteinsIBA 09/2013
1	Fatty Acid Binding Protein 3IBA 09/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2011
1	pentetreotide (OctreoScan)FDA Link 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2003
1	AcidsIBA 09/2001
1	Parathyroid Hormone (Parathormone)IBA 07/2001
1	yttrium 90-DOTA-lanreotideIBA 06/2001
1	Interferon-alpha (Interferon Alfa)IBA 01/2001
1	Glucose (Dextrose)FDA LinkGeneric 12/2000
1	Peptides (Polypeptides)IBA 03/2000
1	RadiopharmaceuticalsIBA 03/2000

Therapy/Procedure

10	Therapeutics 02/2012 - 01/2001
1	Extracorporeal Shockwave Therapy 02/2012
1	Gamma Cameras (Gamma Camera) 10/2003
1	Stem Cell Transplantation 06/2003
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 06/2003
1	Drug Therapy (Chemotherapy) 02/2002
1	Parathyroidectomy 07/2001
1	Aftercare (After-Treatment) 01/2001
1	Intramuscular Injections 06/2000